Xenon Pharmaceuticals, Inc. (XENE)
60.54
-0.23
(-0.38%)
USD |
NASDAQ |
Aug 24, 16:00
60.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Net Income (Quarterly) : -110.74M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -110.74M |
| March 31, 2026 | -102.30M |
| December 31, 2025 | -105.26M |
| September 30, 2025 | -90.90M |
| June 30, 2025 | -84.71M |
| March 31, 2025 | -65.05M |
| December 31, 2024 | -65.68M |
| September 30, 2024 | -62.79M |
| June 30, 2024 | -57.92M |
| March 31, 2024 | -47.93M |
| December 31, 2023 | -44.74M |
| September 30, 2023 | -48.46M |
| June 30, 2023 | -47.46M |
| March 31, 2023 | -41.73M |
| December 31, 2022 | -37.40M |
| September 30, 2022 | -37.15M |
| June 30, 2022 | -31.16M |
| March 31, 2022 | -19.67M |
| December 31, 2021 | -25.56M |
| September 30, 2021 | -15.44M |
| June 30, 2021 | -22.11M |
| March 31, 2021 | -15.76M |
| December 31, 2020 | -12.32M |
| September 30, 2020 | -8.855M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.175M |
| March 31, 2020 | -7.484M |
| December 31, 2019 | -11.38M |
| September 30, 2019 | -8.871M |
| June 30, 2019 | -10.01M |
| March 31, 2019 | -11.34M |
| December 31, 2018 | -8.558M |
| September 30, 2018 | -14.38M |
| June 30, 2018 | -7.801M |
| March 31, 2018 | -3.755M |
| December 31, 2017 | -8.065M |
| September 30, 2017 | -7.742M |
| June 30, 2017 | -7.38M |
| March 31, 2017 | -7.517M |
| December 31, 2016 | -6.004M |
| September 30, 2016 | -7.714M |
| June 30, 2016 | -6.016M |
| March 31, 2016 | -3.263M |
| December 31, 2015 | -3.937M |
| September 30, 2015 | -3.827M |
| June 30, 2015 | 1.168M |
| March 31, 2015 | -4.225M |
| December 31, 2014 | 9.423M |
| September 30, 2014 | 3.595M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Psyence Biomedical Ltd. | -0.7533M |
| Aurinia Pharmaceuticals, Inc. | 37.41M |
| enGene Therapeutics, Inc. | -30.23M |
| Medicus Pharma Ltd. | -8.440M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 110.74M |
| EPS Diluted (Quarterly) | -1.112 |
| Enterprise Value | 4.955B |
| Earnings Yield | -7.84% |
| Normalized Earnings Yield | -7.835 |